Acta Neuropathol

1. GEHIN W, Merlin MS, Harle A, Merlin JL, et al
   Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology.
   Acta Neuropathol. 2026;152:18.
   

   >> Share

   
   

   
   AJNR Am J Neuroradiol

2. SHAH SR, Qazi MS, Riyyan M, Hussain R, et al
   Diffusion Tensor Imaging Analysis Along the Perivascular Space (DTI-ALPS) as an Imaging Biomarker of Glymphatic Dysfunction in Gliomas: A Systematic Review and Meta-Analysis.
   AJNR Am J Neuroradiol. 2026 Aug 13:ajnr.A9593. doi: 10.3174/ajnr.A9593.
   

   >> Share

   
   

   
   BMC Cancer

3. LIU CC, Yu CF, Wang SC, Li HY, et al
   Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.
   BMC Cancer. 2026;26:985.
   

   >> Share

   
   

   
   Cancer Res

4. BACKLUND A, Samaniego CH, Rangaraj R, Campbell C, et al
   Ancestral Genetic Homogeneity in Preclinical Models May Shape Outcome Differences in Pediatric Brain Cancer.
   Cancer Res. 2026;86:3908-3919.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

5. TOM MC, Straube C, Breen WG, Cramer C, et al
   Redefining the Limits of Highly Conformal Radiation Therapy for Brain Metastases.
   Int J Radiat Oncol Biol Phys. 2026;126:1-8.
   

   >> Share

   
   
6. BAILEY MM, Avery C, Hagen MC, Pater LE, et al
   An exploratory analysis of the association between progesterone use and tumor-related visual deficit in women with meningioma.
   Int J Radiat Oncol Biol Phys. 2026 Aug 14:S0360-3016(26)04146.
   

   >> Share

   
   

   
   J Clin Oncol

7. KINSLOW CJ, Minniti G, Brown PD, Vogelbaum MA, et al
   Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.
   J Clin Oncol. 2026 Aug 12:JCO2501846. doi: 10.1200/JCO-25-01846.
   

   >> Share

   
   

   
   J Neurooncol

8. DAMANTE MA, Juncker RB, Little AS, Van Gompel JJ, et al
   Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium.
   J Neurooncol. 2026;179:40.
   

   >> Share

   
   
9. KABIR AS, Peeran Z, Osorio RC, Shukla P, et al
   Socioeconomic factors associated with post-operative biochemical remission in acromegaly.
   J Neurooncol. 2026;179:37.
   

   >> Share

   
   

   
   J Neuropathol Exp Neurol

10. YELDIR N, Sargolzaeimoghaddam M, Sargolzaeimoghaddam M, Cakir A, et al
    Proliferation patterns across meningioma locations: A WHO grade-based analysis.
    J Neuropathol Exp Neurol. 2026 Aug 13:nlag090. doi: 10.1093.
    

    >> Share

    
    

    
    Neuro Oncol

11. KESARWANI A, Griffith AN, Verma S, Hu T, et al
    Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.
    Neuro Oncol. 2026 Aug 8:noag186. doi: 10.1093.
    

    >> Share

    
    
12. BEN-MOUEL OS, Shemesh SZ, Dumanis G, Abofani H, et al
    Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.
    Neuro Oncol. 2026 Aug 10:noag180. doi: 10.1093.
    

    >> Share

    
    
13. AKHAVAN D, Yadav M, Subham S, Jeppson J, et al
    Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma.
    Neuro Oncol. 2026 Aug 10:noag185. doi: 10.1093.
    

    >> Share

    
    
14. TZARIDIS T, Fernandez EC, Eisemann T, Liou A, et al
    CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.
    Neuro Oncol. 2026 Aug 10:noag178. doi: 10.1093.
    

    >> Share

    
    
15. SCHMIDBAUER KJ, von Polenz I, Reis J, Wiegand L, et al
    PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.
    Neuro Oncol. 2026 Aug 14:noag182. doi: 10.1093.
    

    >> Share

    
    

    
    Neurosurgery

16. GHOCHE MT, Miki K, Yuan F, Gecici NN, et al
    Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.
    Neurosurgery. 2026 Feb 2. doi: 10.1227/neu.0000000000003930.
    

    >> Share

    
    

    
    Pediatr Neurol

17. LO MONACO G, Marucci G, Valentini LG, Masnada S, et al
    Sylvian Fissure Meningioma in a Child With KRAS-Related Noonan Syndrome.
    Pediatr Neurol. 2026;183:164-166.
    

    >> Share

    
    

    
    PLoS One

18. MAJUMDER R, Datta P, Moolayadukkam S, Puri IK, et al
    Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM).
    PLoS One. 2026;21:e0354981.
    

    >> Share

    
    
19. 
    Expression of concern: Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
    PLoS One. 2026;21:e0355894.
    

    >> Share

    
    
20. SANCHEZ-HERNANDEZ A, Burgaz S, Louzame-Ruano J, Laguia O, et al
    Targeting telomeres in brain vasculature does not impede initiation and progression of glioblastoma.
    PLoS One. 2026;21:e0355168.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

21. PUIGDELLOSES VALLCORBA M, Rawat K, Soni N, DiMauro A, et al
    Histone H3K27M variants determine myeloid subset dependencies and immune reprogramming in diffuse midline glioma.
    Proc Natl Acad Sci U S A. 2026;123:e2537768123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share